Melior Discovery: New biopharm company formed to advance potential Parkinson's therapy

Melior Discovery Inc. said Tuesday it has completed the formation of its second therapeutic area-focused pharmaceutical company. The company, Melior Pharmaceuticals II in Exton, Pa., will focus on developing a new therapy for Parkinson's disease. Melior Discovery Inc., also of Exton, has transferred all of its intellectual property related to MLR-1019, a therapeutic candidate for Parkinson's disease, into the new company. The spinoff of the asset and its associated intellectual property, according...